Table 3.
PFS | ||||
95% CL of hazard ratio | ||||
Prognostic factors of PFS | p-values | Hazard ratio | CL inf | CL sup |
NIV dosing time | 0.001 | 0.258 | 0.115 | 0.580 |
2nd line NIV | 0.009 | 0.324 | 0.140 | 0.752 |
OS | ||||
95% CL of hazard ratio | ||||
Prognostic factors of OS | p-value | Hazard ratio | CL inf | CL sup |
NIV dosing time | <0.001 | 0.174 | 0.082 | 0.370 |
2nd line NIV | 0.004 | 0.390 | 0.204 | 0.746 |
Adenocarcinoma | <0.014 | 0.460 | 0.248 | 0.854 |
Bone not involved | 0.005 | 0.420 | 0.230 | 0.765 |
Liver not involved | <0.001 | 0.300 | 0.153 | 0.588 |
WHO PS 0 | 0.048 | 2.005 | 1.007 | 3.993 |